BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31976596)

  • 21. Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population.
    Zhou Z; Yang H; Yang L; Yao Y; Dai S; Shi L; Li C; Yang L; Yan Z; Yao Y
    Infect Genet Evol; 2019 Sep; 73():13-20. PubMed ID: 30981880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
    Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
    Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quantities of human papillomavirus 16 E6 mRNA and its relationship with expression of survivin in cervical cancer].
    Liu FY; Xu XM; Liu YZ; Wu YL; Wu DW
    Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):627-30. PubMed ID: 16202321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of p16 INK4a as an indicator for human papillomavirus oncogenic activity in cervical squamous neoplasia.
    Ishikawa M; Fujii T; Saito M; Nindl I; Ono A; Kubushiro K; Tsukazaki K; Mukai M; Nozawa S
    Int J Gynecol Cancer; 2006; 16(1):347-53. PubMed ID: 16445657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression.
    Zhu Y; Han Y; Tian T; Su P; Jin G; Chen J; Cao Y
    Pathol Res Pract; 2018 Mar; 214(3):374-379. PubMed ID: 29487007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
    Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
    Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia].
    Hao M; Wang XL; Bian ML; Liu HT
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):24-6. PubMed ID: 20848842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of HPV16 E7 expression in head and neck carcinoma cell lines and clinical specimens.
    Kitamura K; Nimura K; Ito R; Saga K; Inohara H; Kaneda Y
    Sci Rep; 2020 Dec; 10(1):22138. PubMed ID: 33335126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
    Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
    PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7.
    Sato N; Saga Y; Uchibori R; Tsukahara T; Urabe M; Kume A; Fujiwara H; Suzuki M; Ozawa K; Mizukami H
    Int J Oncol; 2018 Mar; 52(3):687-696. PubMed ID: 29344635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delta-Like Ligand-Notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical Cancer Prognosis.
    Khelil M; Griffin H; Bleeker MCG; Steenbergen RDM; Zheng K; Saunders-Wood T; Samuels S; Rotman J; Vos W; van den Akker BE; de Menezes RX; Kenter GG; Doorbar J; Jordanova ES
    Cancer Res; 2021 Apr; 81(7):1909-1921. PubMed ID: 33500246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state.
    Hanning JE; Saini HK; Murray MJ; Caffarel MM; van Dongen S; Ward D; Barker EM; Scarpini CG; Groves IJ; Stanley MA; Enright AJ; Pett MR; Coleman N
    J Pathol; 2013 Nov; 231(3):354-66. PubMed ID: 23913724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia.
    Krishnappa P; Mohamad IB; Lin YJ; Barua A
    Diagn Pathol; 2014 Nov; 9():202. PubMed ID: 25361681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSK3β mediates the carcinogenic effect of HPV16 in cervical cancer.
    Ma C; Zeng C; Jin L; Yang Y; Li P; Chen L; Wang J
    Sci Rep; 2015 Nov; 5():16555. PubMed ID: 26560046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The synergic effect of HPV infection and epigenetic anomaly of the p16 gene in the development of cervical cancer.
    Ahmad A; Raish M; Shahid M; Batra S; Batra V; Husain SA
    Cancer Biomark; 2017 Jul; 19(4):375-381. PubMed ID: 28453456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.
    Zhu D; Ye M; Zhang W
    Int J Clin Exp Pathol; 2015; 8(5):4981-9. PubMed ID: 26191191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.